✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Driving SafetyThc MetabolismPatient CounselingCognitive FunctionCannabis Pharmacokinetics Why This Matters Understanding cannabis clearance and next-day...
THC levels in blood and urine are "unreliable" indicators of driving impairment – leafie
WHY IT MATTERS: Patients who use cannabis medicinally could face legal consequences for impaired driving based on biological thresholds that do not accurately reflect whether they were actually impaired at the time of driving. CLINICAL OVERVIEW: The relationship between THC concentration in biological fluids and actual driving impairment is far more complex than a simple number can capture. THC is highly lipophilic, meaning it distributes rapidly into tissues and does not remain in blood proportionally to psychoactive effect, which makes blood levels a poor proxy for functional intoxication.
Cannabis research: India to start human trials for medicinal marijuana – NewsBytes
WHY IT MATTERS: If India’s human trials produce strong safety and efficacy data, it could accelerate regulatory acceptance of medicinal cannabis across South and Southeast Asia, potentially expanding patient access in regions where options are currently very limited. CLINICAL OVERVIEW: India’s launch of human clinical trials for medicinal cannabis represents a significant regulatory and scientific shift for a country with historically strict drug policies. These trials will generate controlled safety and efficacy data across specific medical conditions, helping to establish evidence-based frameworks for potential therapeutic use.